The PARP inhibitors Market was valued at USD 4723.5 Million and is expected to grow at a strong CAGR of around 12.9% during the forecast period (2024-2032) The PARP inhibitor market has experienced significant growth in recent years, driven by increasing cancer incidence and advancements in targeted cancer therapies. The market is projected to expand at a robust CAGR over the forecast period,...